| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Artilces |
Departments of Neurology [C. S. H., W. A. W.], Pediatrics [C. S. H., W. A. W.], Neurological Surgery [C. S. H., W. A. W.], Laboratory Medicine [J. G. H., D. P., A. J., J. W. G., W. A. W.], Cancer Center [J. G. H., J. F., D. P., D. G. A., A. J., W. A. W.], and Cancer Research Institute [J. F., D. G. A., A. J., J. W. G.], University of California, San Francisco, California 94143-0114; Department of Laboratory Medicine and Pathology, Mayo Clinic and Foundation, Rochester, Minnesota 55905 [M. E. L., R. J.]; Childrens Hospital Oakland Research Institute, BACPAC Resources, Oakland, California 94609-1809 [K. O., P. J. d. J.]; and Roswell Park Cancer Institute, Buffalo, New York 14263 [N. J. N.]
ABSTRACT
Neuroblastoma, the third most common tumor of childhood, is a complex disease in which few genetic mutations have been identified.Mice expressing a human MYCN oncogene driven by the rat tyrosine hydroxylase promoter (TH-MYCN) represent an animal model for this disorder. We performed microarray-based comparative genomic hybridization analysis on murine tumors, identifying gains on chromosomes 1, 3, 11, 14, 17, and 18 and losses on chromosomes 5, 9, and 16. Fluorescence in situ hybridization analysis confirmed an amplicon on chromosome 18 as the site of TH-MYCN transgene integration. Selected tumors with localized gains of chromosome 11 delineate a 15-Mb region orthologous to human chromosome 17q and help to narrow the minimal region gained in human tumors. We observed clustered loss of chromosomes 5, 9, and 16, orthologous to a similar pattern of combined loss of chromosomes 3p, 4p, and 11q in human tumors. These data demonstrate conservation of many genetic changes in murine and human neuroblastoma and suggest that further delineation of genetic abnormalities in murine tumors may identify genes important in human disease.
This article has been cited by other articles:
![]() |
L. S. Collier, D. J. Adams, C. S. Hackett, L. E. Bendzick, K. Akagi, M. N. Davies, M. D. Diers, F. J. Rodriguez, A. M. Bender, C. Tieu, et al. Whole-Body Sleeping Beauty Mutagenesis Can Cause Penetrant Leukemia/Lymphoma and Rare High-Grade Glioma without Associated Embryonic Lethality Cancer Res., November 1, 2009; 69(21): 8429 - 8437. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Chayka, D. Corvetta, M. Dews, A. E. Caccamo, I. Piotrowska, G. Santilli, S. Gibson, N. J. Sebire, N. Himoudi, M. D. Hogarty, et al. Clusterin, a Haploinsufficient Tumor Suppressor Gene in Neuroblastomas J Natl Cancer Inst, May 6, 2009; 101(9): 663 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Hogarty, M. D. Norris, K. Davis, X. Liu, N. F. Evageliou, C. S. Hayes, B. Pawel, R. Guo, H. Zhao, E. Sekyere, et al. ODC1 Is a Critical Determinant of MYCN Oncogenesis and a Therapeutic Target in Neuroblastoma Cancer Res., December 1, 2008; 68(23): 9735 - 9745. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guan, W.-L. Kuo, J. L. Stilwell, H. Takano, A. V. Lapuk, J. Fridlyand, J.-H. Mao, M. Yu, M. A. Miller, J. L. Santos, et al. Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer Clin. Cancer Res., October 1, 2007; 13(19): 5745 - 5755. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, T. Yu, M. Morishima, A. Pao, J. LaDuca, J. Conroy, N. Nowak, S.-I. Matsui, I. Shiraishi, and Y. E. Yu Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities Hum. Mol. Genet., June 1, 2007; 16(11): 1359 - 1366. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chesler, C. Schlieve, D. D. Goldenberg, A. Kenney, G. Kim, A. McMillan, K. K. Matthay, D. Rowitch, and W. A. Weiss Inhibition of Phosphatidylinositol 3-Kinase Destabilizes Mycn Protein and Blocks Malignant Progression in Neuroblastoma Cancer Res., August 15, 2006; 66(16): 8139 - 8146. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bussey, K. Chin, S. Lababidi, M. Reimers, W. C. Reinhold, W.-L. Kuo, F. Gwadry, Ajay, H. Kouros-Mehr, J. Fridlyand, et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol. Cancer Ther., April 1, 2006; 5(4): 853 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-M. Kim, S.-H. Yim, J.-S. Lee, M.-S. Kwon, J.-W. Ryu, H.-M. Kang, H. Fiegler, N. P. Carter, and Y.-J. Chung Genome-Wide Screening of Genomic Alterations and Their Clinicopathologic Implications in Non-Small Cell Lung Cancers Clin. Cancer Res., December 1, 2005; 11(23): 8235 - 8242. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Hodgson, T. Malek, S. Bornstein, S. Hariono, D. G. Ginzinger, W. J. Muller, and J. W. Gray Copy Number Aberrations in Mouse Breast Tumors Reveal Loci and Genes Important in Tumorigenic Receptor Tyrosine Kinase Signaling Cancer Res., November 1, 2005; 65(21): 9695 - 9704. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Scacheri, A. L. Kennedy, K. Chin, M. T. Miller, J. G. Hodgson, J. W. Gray, S. J. Marx, A. M. Spiegel, and F. S. Collins Pancreatic Insulinomas in Multiple Endocrine Neoplasia, Type I Knockout Mice Can Develop in the Absence of Chromosome Instability or Microsatellite Instability Cancer Res., October 1, 2004; 64(19): 7039 - 7044. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Guillaud-Bataille, A. Valent, P. Soularue, C. Perot, M.-d.-M. Inda, A. Receveur, S. Smaili, H. R. Crollius, J. Benard, A. Bernheim, et al. Detecting single DNA copy number variations in complex genomes using one nanogram of starting DNA and BAC-array CGH Nucleic Acids Res., July 29, 2004; 32(13): e112 - e112. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Hager, J. G. Hodgson, J. Fridlyand, S. Hariono, J. W. Gray, and D. Hanahan Oncogene Expression and Genetic Background Influence the Frequency of DNA Copy Number Abnormalities in Mouse Pancreatic Islet Cell Carcinomas Cancer Res., April 1, 2004; 64(7): 2406 - 2410. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Verschuren, J. G. Hodgson, J. W. Gray, S. Kogan, N. Jones, and G. I. Evan The Role of p53 in Suppression of KSHV Cyclin-induced Lymphomagenesis Cancer Res., January 15, 2004; 64(2): 581 - 589. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |